Viela Bio's Spinoff / Spinout Round

Viela Bio raised a round of funding on February 28, 2018. Investors include MedImmune.

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases by selectively targeting shared critical pathways that are the r…

Articles about Viela Bio's Spinoff / Spinout Round: